New combo therapy aims to shrink abdominal tumors in colorectal cancer patients

NCT ID NCT07079462

Recruiting now Disease control Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated May 16, 2026 · Updated 18 times

Summary

This study tests whether adding a special type of PET scan-guided radiation to standard second-line treatment works better than standard treatment alone for colorectal cancer that has spread to the abdomen. About 40 adults whose cancer worsened after first-line therapy will be randomly assigned to one of two groups. The goal is to see if the new combination shrinks tumors more effectively and safely.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fudan University Shanghai Cancer Center
RECRUITING

Shanghai, Shanghai Municipality, 200032, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Fudan University Shanghai Cancer Center
COMPLETED

Shanghai, China

Conditions

Explore the condition pages connected to this study.

COLORECTAL CANCER FAPI PET PERITONEAL (METASTATIC) CANCER